Cancer of the uterine cervix is the second largest cause of cancer deaths in women, and its
toll is greatest in populations that lack screening programmes to detect precursor lesions …

Human papillomavirus (HPV) vaccines for the prevention of cervical cancer have produced
encouraging results in recent clinical trials, and expectations are high that one or more …

Universal deployment of organized or opportunistic screening with Pap cytology in high and
middle income countries has been the primary reason for the substantial reductions in …

In the recent period following the approval of the first vaccine targeted against human
papillomavirus, it is imperative that we re-evaluate the past, present, and future of cervical …

Vaccination against human papillomavirus (HPV) promises to dramatically decrease the
incidence of HPV-related diseases, including cervical cancer. Although this vaccine is …

Cervical cancer is one of the most common cancers threatening women's health, and the
persistent infection of high-risk human papillomavirus (HPV) is closely related to the …

Human papillomavirus (HPV) is the most common sexually transmitted disease, worldwide.
Primary prevention thorough vaccination si able to reduce the burden of HPV-related …

The finding that cervical cancer only occurs in women infected with specific,“high-risk” types
of the human papillomavirus (HPV) has led to the development of novel, non-cytology-based …

Introduction: Recently, the evidence on efficacy and safety of prophylactic HPV vaccines
derived from randomized trials was published in the Cochrane database of Systematic …

Abstract Learning Objectives After completing this course, the reader will be able to: Discuss
the epidemiology and pathogenesis of HPV and HPV-associated diseases. Explain the …